|
1）Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003; 290(17): 2292-300
|
|
|
|
2）Wang L, Sharifi BG, Pan T, et al. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J Am Coll Cardiol. 2006; 48(7): 1459-68
|
|
|
|
|
|
3）Roma P, Gregg RE, Meng MS, et al. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. J Clin Invest. 1993; 91(4): 1445-52
|
|
|
|
|
|
4）Viswambharan H, et al. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ Res. 2004; 94: 918-25
|
|
|
|
|
|
5）Kruger AL, et al. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation. 2005; 111: 3126-34
|
|
|
|
|
|
6）Navab M, et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005; 25: 1325-31
|
|
|
|
|
|
7）Sumi M, et al. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007; 27: 813-8
|
|
|
|
|
|
8）Matsuo Y, et al. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis. 2007; 194: 159-68
|
|
|
|
|
|
9）Kiya Y, et al. Reconstituted high-density lipoprotein prevents pathological remodeling after myocardial infarction in rats. Circ J. 2005; 69 Supple: 646
|
|
|
|
|
|
10）Imaizumi S, Miura S, Nakamura K, et al. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol. 2008; 51: 1604-12
|
|
|
|
|
|
11）Zhang B, Fan P, Shimoji E, et al. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits. Arterioscler Thromb Vasc Biol. 2004; 24(10): 1910-5
|
|
|
|
|
|
12）Zhang B, Uehara Y, Hida S, et al. Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis. J Lipid Res. 2007; 48(5): 1175-89
|
|
|
|
|
|
13）Zhang B, Miura S, Fan P, et al. ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis. Atherosclerosis. 2006; 188(1): 95-101
|
|
|
|
|
|
14）朔啓二郎．動脈硬化性疾患を標的としたHDL治療の展望．循環器専門医．2010; 18: 217-22
|
|
|
|
|
15）Brown BG, et al. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011; 161: 471-7
|
|
|
|
|